Showing results (91-100 of 433) with videos related to

Sort By:
Pageof 44
European Heart Journal|April 20, 2010
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trialDavid A Morrow, Elliott M Antman, Keith A A Fox, et al.
Ultrasound in Medicine & Biology|April 16, 2005
Laser Doppler anemometry measurements of the shear stresses on ultrasonic contrast agent microbubbles attached to agarMairead B Butler, Carmel M Moran, Tom Anderson, et al.
Annals of Internal Medicine|June 3, 2004
Association of statin therapy with outcomes of acute coronary syndromes: the GRACE studyFrederick A Spencer, Jeanna Allegrone, Robert J Goldberg, et al.
Clinical Cardiology|December 19, 2019
Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT RegistryLaurie-Anne Boivin-Proulx, Ariane Deneault-Marchand, Alexis Matteau, et al.
Circulation|February 26, 2003
Early and late effects of clopidogrel in patients with acute coronary syndromesSalim Yusuf, Shamir R Mehta, Feng Zhao, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 10, 2025
Dual pathway inhibition in patients with coronary artery disease (CAD) in clinical practice in Germany: results from the German CAD subgroup of the XATOA RegistryUwe Zeymer, Rupert M Bauersachs, Nikolaos Dagkonakis, et al.
Journal of the American College of Cardiology|April 3, 2010
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient dataKeith A A Fox, Tim C Clayton, Peter Damman, et al.
Plos One|December 4, 2009
Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scoresKrishna G Aragam, Umesh U Tamhane, Eva Kline-Rogers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2013
Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosisAndrew J Lucking, Kyle R Gibson, Elspeth E Paterson, et al.
European Heart Journal|September 1, 2010
Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarctionFrançois Schiele, Matthias Hochadel, Marco Tubaro, et al.
Pageof 44